Laffer Investments Increased Amgen INC (AMGN) Stake as Shares Declined

May 16, 2018 - By Russell Jones

Amgen Inc. (NASDAQ:AMGN) Corporate LogoBig Money Sentiment increased to 1.22 in Q4 2017. It has change of 0.23, from 2017Q3’s 0.99. The ratio is positive due to AMGN positioning: 73 sold and 458 reduced. 122 funds took holdings and 527 increased holdings. Investors holded 555.05 million in 2017Q3 but now own 551.71 million shares or 0.60% less. Systematic Financial Mngmt Limited Partnership holds 0.06% of its capital in Amgen Inc. (NASDAQ:AMGN) for 17,529 shs. Penobscot Invest Communication Inc holds 26,335 shs. Saturna Corp owns 364,811 shs or 1.94% of their US capital. Moreover, West Oak Capital Limited Co has 1.05% invested in Amgen Inc. (NASDAQ:AMGN). Biondo Advisors Lc reported 5,800 shs stake. Parametric Associate Limited Co reported 2.35 million shs. Amg Trust Commercial Bank holds 14,336 shs or 0.16% of its capital. Stonehearth Capital Ltd has invested 0.03% of its capital in Amgen Inc. (NASDAQ:AMGN). 1,694 were reported by Mckinley Cap Mgmt Ltd Delaware. Janney Cap Mngmt Limited invested 0.5% in Amgen Inc. (NASDAQ:AMGN). Caisse De Depot Et Placement Du Quebec has invested 0.17% in Amgen Inc. (NASDAQ:AMGN). Fifth Third Retail Bank owns 500,019 shs. Crawford Counsel, Georgia-based fund reported 7,001 shs. Jnba Fincl Advisors holds 1,180 shs. 34,259 are owned by Ftb Advsrs Inc.

AMGN registered $1.37 million net activity with 0 insider buys and 5 insider sales since December 12, 2017.

In Amgen Inc (AMGN) was upped the stake owned by Laffer Investments. The decrease is 60.06% according to 2017Q4 SEC filling. 1,555 shares were bought by Laffer Investments as the company’s stock declined 2.99% with the market. The biological products (no diagnostic substances) company reported $720.64 million value for the 2017Q4. Now the institutional investor is holding 4,144 shares, compared to the 2,589 from the previous quarter. $115.75 billion is the MC of Amgen Inc. AMGN is hitting $173.8 during the last trading session, after increased 1.63%.Currently Amgen Inc. is uptrending after 3.78% change in last May 16, 2017. AMGN has 2.13M shares volume. The stock underperformed the S&P 500 by 7.77%.

Laffer Investments decreased its stake in Ishares Floating Rate Bond Etf (FLOT) by 733 shares to 10,731 shares, valued at $545.35 million in 2017Q4, according to the filing. It manages about $614.32M and $399.05B US Long portfolio. Laffer Investments has cut its stake in Nextera Energy Inc (NYSE:NEE) and also reduced its holding in Paychex Inc (NASDAQ:PAYX) by 1,249 shares in the quarter, for a total of 39,883 shares.

Another two news for Amgen Inc. (NASDAQ:AMGN) were briefly posted by: Seekingalpha.com on May 16, 2018 with title “Expanded label for Amgen’s Repatha approved in Europe”. The other Fool.com‘s article was titled “Better Buy: Amgen Inc. vs. Biogen Inc.” and posted on May 15, 2018.

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

A total of 14 analysts rate Amgen Inc (NASDAQ:AMGN) as follows: 7 “Buy”, 7 “Hold” and 0 “Sell”. Тherefore 50% are bullish. (NASDAQ:AMGN) has 17 ratings reports on 16 May 2018 according to StockzIntelligence. On Monday, February 12 the firm has “Buy” rating given by Mizuho. The company rating was maintained by BMO Capital Markets on Friday, February 2. On Friday, February 2 Morgan Stanley maintained Amgen Inc. (NASDAQ:AMGN) with “Overweight” rating. On Wednesday, April 25 Morgan Stanley maintained Amgen Inc. (NASDAQ:AMGN) with “Overweight” rating. On Thursday, February 1 the stock has “Buy” rating by Piper Jaffray. In Friday, February 2 report Credit Suisse maintained it with “Neutral” rating and $194 target. On Wednesday, January 24 the stock has “Neutral” rating by JP Morgan. On Thursday, February 1 the stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Cowen & Co. On Tuesday, January 23 the stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given by Argus Research. On Thursday, April 5 the firm earned “Equal-Weight” rating by Barclays Capital.

Amgen Inc. (NASDAQ:AMGN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.